Skip to main content
← Back to work

Works cited by this work

120 works

Work: The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

  1. Untitled

    Other7 citations
    ABI
  2. Untitled

    Other3 citations
    ABI
  3. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

    Hila Magen, Eli Muchtar

    Review article20162 citations
    ABI
  4. Immunopathogenesis of Rheumatoid Arthritis

    Gary S. Firestein, Iain B. McInnes

    Review article20172 citations
    ABI
  5. Untitled

    Other2 citations
    ABI
  6. SLAM family receptors in normal immunity and immune pathologies

    Ning Wu, André Veillette

    Review article20152 citations
    ABI
  7. Diagnosis and Management of Multiple Myeloma

    Andrew J. Cowan, Damian J. Green, Mary Kwok +6

    Review article20222 citations
    ABI
  8. Cancer treatment and survivorship statistics, 2022

    Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia +5

    Article20222 citations
    ABI
  9. Global epidemiology of rheumatoid arthritis

    Axel Finckh, Benoît Gilbert, Bridget Hodkinson +5

    Review article20222 citations
    ABI
  10. SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

    Emily Chu, Jian Wu, Stacey S. Kang +1

    Review article20232 citations
    ABI
  11. Untitled

    Other1 citations
    ABI
  12. Untitled

    Other1 citations
    ABI
  13. Untitled

    Other1 citations
    ABI
  14. Untitled

    Other1 citations
    ABI